key: cord-0752102-572up7us authors: Price, D. J.; Shearer, F. M.; Meehan, M. T.; McBryde, E.; Moss, R.; Golding, N.; Conway, E. J.; Dawson, P.; Cromer, D.; Wood, J.; Abbott, S.; McVernon, J.; McCaw, J. M. title: Early analysis of the Australian COVID-19 epidemic date: 2020-04-30 journal: nan DOI: 10.1101/2020.04.25.20080127 sha: b0b5224d56df3d521ce6a7b65b8f551108fdc452 doc_id: 752102 cord_uid: 572up7us As of 18 April 2020, there had been 6,533 confirmed cases of COVID-19 in Australia. Of these, 67 had died from the disease. The daily count of new confirmed cases was declining. This suggests that the collective actions of the Australian public and government authorities in response to COVID-19 were sufficiently early and assiduous to avert a public health crisis - for now. Analysing factors, such as the intensity and timing public health interventions, that contribute to individual country experiences of COVID-19 will assist in the next stage of response planning globally. Using data from the Australian national COVID-19 database, we describe how the epidemic and public health response unfolded in Australia up to 13 April 2020. We estimate that the effective reproduction number was likely below 1 (the threshold value for control) in each Australian state since mid-March and forecast that hospital ward and intensive care unit occupancy will remain below capacity thresholds over the next two weeks. importation of COVID-19 into Australia. Their purpose was to delay the establishment of an epidemic, buying valuable time for health authorities to plan and prepare. During the month of February, with extensive testing and case targeted interventions in place (case isolation and contact quarantine), Australia detected and managed only 12 cases. Meanwhile, globally, the geographic extent of transmission and daily counts of confirmed cases and deaths continued to increase drastically [16] . In early March, Australia extended travel restrictions to a number of countries with large uncontained outbreaks, namely Iran (as of 1 March) [17] , South Korea (as of 5 March) [18] and Italy (as of 11 March) [19] . Despite these measures, the daily case counts rose sharply in Australia during the first half of March. While the vast majority of these cases were connected to travellers returning to Australia from overseas, localised community transmission had been reported in areas of Sydney and Melbourne. Crude plots of the cumulative number of cases by country showed Australia on an early trajectory similar to the outbreaks experienced in China, Europe and the United States, where health systems had become or were becoming overwhelmed [20] . From 16 March, the Australian Government progressively implemented a range of social distancing measures in order to reduce and prevent further community transmission [21] . The day before, authorities had imposed a self-quarantine requirement on all international arrivals [22] . On 19 March, Australia closed its borders to all non-citizens and non-residents [23] , and on March 27, moved to a policy of mandatory quarantine for any returning citizens and residents [24] . By 29 March, social distancing measures had been escalated to the extent that all Australians were strongly advised to leave their homes only for limited essential activities and public gatherings were limited to two people [25] . By late March, daily counts of new cases appeared to be declining, suggesting that these measures had successfully reduced transmission. Quantifying changes in the rate of spread of infection over the course of an epidemic is critical for monitoring the collective impact of public health interventions and forecasting the short-term clinical burden. A key indicator of transmission in context is the effective reproduction number (R eff ) -the average number of secondary infections caused by an infected individual in the presence of public health interventions and for which no assumption of 100% susceptibility is made. If control efforts are able to bring R eff below 1, then on average there will be a decline in the number of new cases reported. The decline will become apparent after a delay of approximately one incubation period plus time to case detection and reporting following implementation of the control measure (i.e., at least two weeks). Using case counts from the Australian national COVID-19 database, we estimated R eff over time for each Australian state from 24 February to 5 April 2020 ( Figure 2 ). We used a statistical method that estimates time-varying R eff by using an optimally selected moving average window to smooth the curve and reduce the impact of localised clusters and outbreaks that may cause large fluctuations [26] . Importantly, the method accounts for time delays between illness onset and case notification. Incorporation of this lag is critical for accurate interpretation of the most recent data in the analysis, to be sure that an observed drop in the number of reported cases reflects an actual drop in case numbers. Results show that R eff has likely been below 1 in each Australian state since early-to-mid March. These estimates are geographically averaged results over large areas and it is possible that R eff was and remains much higher than 1 in a number of localised settings (see Figure 2 ). . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 30, 2020. . The estimated time-varying R eff value is based on cases that have been identified as a result of local transmission, whereas imported cases only contribute to the force of infection [27] . Imported and locally acquired cases were assumed to be equally infectious. The method for estimating R eff is sensitive to this assumption. Hence, we performed a sensitivity analysis to assess the impact of stepwise reductions in the infectiousness of imported cases on R eff as a result of quarantine measures implemented over time (see Figures S2, S3, and S4 ). The sensitivity analyses suggest that R eff may well have dropped below 1 later than shown in Figure 2 . Next we used our estimates of time-varying R eff to forecast the short-term clinical burden in Australia. Estimates were input into a mathematical model of disease dynamics that was extended to account for imported cases. A sequential Monte Carlo method was used to infer the model parameters and appropriately capture the uncertainty [28], conditional on each of a number of sampled R eff trajectories up to 5 April, from which point they were assumed to be constant. The model was subsequently projected forward from April 14 to April 28, to forecast the number of reported cases, assuming a symptomatic detection probability of 80%, within the range estimated by [29] . The number of new daily hospitalisations and ICU admissions were estimated from recently observed and forecast case counts. Specifically, the age distribution of projected cases, and age-specific probabilities of hospitalisation and ICU admission, were extracted from Australian age-specific data on confirmed cases, assuming that this distribution would remain unchanged (see Table S2 ). In order to calculate the number of occupied ward/ICU beds per day, length-of-stay in a ward bed and ICU bed were assumed to be Gamma distributed with means (SD) of 11 (3.42) days and 14 (5.22) days, respectively. Our results indicate that with the current public health interventions in place Australia's hospital ward and ICU occupancy will remain well below capacity thresholds over the next two weeks. Our analysis suggests that Australia's combined strategy of early, targeted management of the risk of importation, case targeted interventions, and broad-scale social distancing measures applied prior to the onset of detected widespread community transmission has substantially mitigated the first wave of COVID-19. More detailed analyses are required to assess the relative impact of specific response measures, and this information will be crucial for the next phase of response planning. We further anticipate that the Australian health care system is well positioned to manage projected COVID-19 case loads over the next two weeks. Ongoing situational assessment and monitoring of forecasted hospital and ICU demand will be essential for managing possible future relaxation of broad-scale community interventions. Vigilance for localised increases in epidemic activity and in particular for outbreaks in vulnerable populations such as residential aged care facilities, where a high proportion of cases are likely to be severe, must be maintained. While the symptomatic case detection rate is estimated to be very high in Australia (between 77 and 100% [29]), one largely unknown factor at present is the number of asymptomatic, mild and undiagnosed infections. Even if this number is high, the Australian population would still be largely susceptible to infection. Accordingly, complete relaxation of the measures currently in place would see a rapid resurgence in epidemic activity. This problem is not unique to Australia. Many countries with intensive social distancing measures in place are starting to grapple with their options and time frames for a gradual return to relative 4 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 30, 2020. . There are difficult decisions ahead for governments, and for now Australia is one of the few countries fortunate enough to be able to plan the next steps from a position of relative calm as opposed to crisis. This study represents surveillance data reported through the Communicable Diseases Network Australia (CDNA) as part of the nationally coordinated response to COVID-19. We thank public health staff from incident emergency operations centres in state and territory health departments, and the Australian Government Department of Health, along with state and territory public health laboratories. We thank members of CDNA for their feedback and perspectives on the study results. We thank Dr Jonathan Tuke for helping to assemble Australian national and state announcements of COVID-19 response measures. Analysis code is included in the supplementary materials. Datasets analysed and generated during this study are included in the supplementary materials. For estimates of the time-varying effective reproduction number (Figure 2 ), the complete line listed data within the Australian national COVID-19 database are not publicly available. However, we provide the cases per day by notification date and state (as shown in Figures 1 and S1 ) which, when supplemented with the estimated distribution of the delay from symptom onset to notification (samples from this distribution are provided as a data file), analyses of the time-varying effective reproduction number can be performed. [3] World Health Organization. Coronavirus disease (COVID-19) Situation Report -88. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports, April 17 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 30, 2020. . [14] Australian Bureau of Statistics, Overseas Arrivals and Departures, Australia. ' [15] Nicole A Errett, Lauren M Sauer, and Lainie Rutkow. An integrative review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure. J Emerg Manag, (1):7-14, 2020. 6 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. . 7 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. 8 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. We provide a brief overview of the method below, focusing on how the analysis was adapted to the Australian context. We used line-lists of reported cases for each Australian state/territory extracted from the national COVID-19 database. The line-lists contain the date when the individual first exhibited symptoms, date when the case notification was received by the jurisdictional health department and where the infection was acquired (i.e., overseas or locally). A pre-hoc statistical analysis was conducted in order to estimate a distribution of the reporting delays from the line-lists of cases, using the code base provided by [26] . The estimated reporting delay is assumed to remain constant over time. These reporting delays are used to: i) infer the time of symptom onset for those without this information, and; ii) infer how many cases in recent days are yet to be recorded. Adjusting for reporting delays is critical for inferring when a drop in observed cases reflects a true drop in cases. Trends identified using this approach are robust to under-reporting, assuming that it is constant. However, absolute values of R eff may be biased by reporting rates. Pronounced changes in reporting rates may also impact the trends identified. However, evidence suggests that Australia's symptomatic case ascertainment rate is very high (between 77 and 100%) and that this rate has been relatively stable over time [29] . Estimating the effective reproduction number over time Briefly, the R eff was estimated for each day from 24 February 2020 up to 5 April 2020 using line list data -date of symptom onset, date of report, and import status -for each state. The method assumes that the serial interval (i.e., time between symptom onset for an index and secondary case) is uncertain, with a mean of 4.7 days (95% CrI: 3.7, 6.0) and a standard deviation of 2.9 days (95% CrI: 1.9, 4.9), as estimated from early outbreak data in Wuhan, China [34]. Combining the incidence over time with the uncertain distribution of serial intervals allows us to estimate R eff over time. A prior distribution was specified for R eff , with mean 2.6 (informed by [35] ) and a broad standard deviation of 2 so as to allow for a range of R eff values. Finally, R eff is estimated 9 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. using an optimally selected moving average window in order to smooth the curve and reduce the impact of localised events (e.g., local outbreaks) causing large variations. Note that up to 20% of reported cases in the Australian national COVID-19 database do not have a reported import status (see Figure 1 ). Conservatively, we assumed that all cases with an unknown or unconfirmed source of acquisition were locally acquired. A large proportion of cases reported in Australia from January until now were imported from overseas. It is critical to account for two distinct populations in the case notification dataimported and locally acquired -in order to perform robust analyses of transmission in the early stages of this outbreak. The estimated time-varying R eff value is based on cases that have been identified as a result of local transmission, whereas imported cases contribute to transmission only [27] . Specifically, the method assumes that local and imported cases contribute equally to transmission. The results under this assumption are presented in Figure 2 . However, given quarantine measures put in place at different times ( Figure S5 ), it is likely that imported cases contributed relatively less to transmission than locally acquired cases. We explored this via a sensitivity analysis. Prior to 15 March, returning Australian residents and citizens (and their dependents) from mainland China were advised to self-quarantine. Note that further border measures were implemented during this period, including enhanced testing and provision of advice on arrivals from selected countries based on a risk assessment tool developed in early February [11] . On 15 March, Australian authorities imposed a self-quarantine requirement on all international arrivals, and from 27 March, moved to a mandatory quarantine policy for all international arrivals. Hence, we assumed that prior to 15 March, 10%, 20% and 50% of imported cases did not contribute to transmission ( Figures S2, S3 and S4 , respectively). Between 15 and 27 March, we assumed that 50%, 50% and 80% of imported cases did not contribute to transmission. From 27 March, we assumed that 99% of imported cases did not contribute to transmission in each scenario. We used the estimates of time-varying R eff to forecast the national short-term ward/ICU occupancy due to COVID-19 patients. The forecasting method combines an SEEIIR (susceptible-exposed-infectious-recovered) population model of infection with daily COVID-19 case notification counts, through the use of a bootstrap particle filter. The daily case counts by date of diagnosis were modelled using a negative binomial distribution with a fixed dispersion parameter k, and the expected number of cases was proportional to the daily incidence of symptomatic infections in the SEEIIR model; this proportion was characterised by the observation probability. Natural disease history parameters were sampled from narrow uniform priors, based on values reported in the literature for COVID-19, and each particle was associated with an R eff trajectory that was 10 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. . drawn from the state/territory R eff trajectories in Figure 2 up to 5 April, from which point they are assumed to be constant. The model was subsequently projected forward from April 14 to April 28, to forecast the number of reported cases, assuming a detection probability of 80% (informed by [29] ). In order to account for imported cases, we used daily counts of imported cases to construct a time-series of the expected daily importation rate and, assuming that such cases were identified one week after initial exposure, introduced exposure events into each particle trajectory by adding an extra term to the force of infection equation. Model equations below describe the flow of individuals in the population from the susceptible class (S), through two exposed classes (E 1 , E 2 ), two infectious classes (I 1 , I 2 ) and finally into a removed class (R). Two exposed and infectious classes are chosen such that the duration of time in the exposed or infectious period has an Erlang distribution. The corresponding parameters are given in Table S1 . With initial conditions: With time-varying transmission rate: 11 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. . Value/Prior distribution σ Inverse of the mean incubation period U (4 −1 , 3 −1 ) γ Inverse of the mean infectious period U (10 −1 , 9 −1 ) τ Time of first exposure U (0, 28) p obs Probability of observing a case 0.8 k Dispersion parameter on Negative-Binomial 100 observation model Table S1 : SEEIIR forecasting model parameters. The number of new daily hospitalisations and ICU admissions were estimated from recently observed and forecasted case counts by: 1. Estimating the age distribution of projected case counts using data from the national COVID-19 database on the age-specific proportion of confirmed cases; 2. Estimating the age-specific hospitalisation and ICU admission rates using data from the national COVID-19 database. We assumed that all hospitalisations and ICU admissions were either recorded or were missing at random (31% and 58% of cases had no information recorded under hospitalisation or ICU status, respectively); 3. Randomly drawing the number of hospitalisations/ICU admissions in each age-group (for both the observed and projected case counts) from a binomial distribution with number of trials given by the expected number of cases in each age group (from 1), and probability given by the observed proportion of hospitalisations/ICU admissions by age group (from 2). Finally, in order to calculate the number of occupied ward/ICU beds per day, length-ofstay in a ward bed and ICU bed were assumed to be Gamma distributed with means (SD) of 11 (3.42) days and 14 (5.22) days, respectively. We assumed ICU admissions required a ward bed prior to, and following, ICU stay for a Poisson distributed number of days with mean 2.5. Relevant Australian data were not available to parameterise a model that captures the dynamics of patient flow within the hospital system in more detail. This model provides a useful indication of hospital bed occupancy based on limited available data and may be updated as more specific data (e.g., on COVID-19 patient length-of-stay) becomes available. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. . 13 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. January 2020 (first case detected) to 13 April 2020. Dates of selected key border and social distancing measures implemented by Australian authorities are indicated by annotations above the plotted case counts. These measures were in addition to case targeted interventions (case isolation and contact quarantine) and further border measures, including enhanced testing and provision of advice, on arrivals from other selected countries, based on a riskassessment tool developed in early February [11] . Note that Australian citizens and residents (and their dependants) were exempt from travel restrictions, but upon returning to Australia were required to quarantine for 14 days from the date of arrival. A full timeline of social distancing and border measures is provided in Figure S5 . 14 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. 15 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. 18 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. 19 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. 20 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 30, 2020. Figure S5 : Timeline of border and social distancing measures implemented in Australia up to 4 April 2020. These measures were in addition to case targeted interventions, specifically case isolation and quarantine of their contacts. Note 1: Between 1 February and 15 March, further border measures were introduced, including enhanced testing and provision of advice on arrivals from other selected countries, based on a risk-assessment tool developed in early February [11] . Note 2: Australian citizens and residents (and their dependants) were exempt from travel restrictions but upon returning to Australia were required to quarantine for 14 days from the date of arrival. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 30, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 30, 2020. . https://doi.org/10.1101/2020.04.25.20080127 doi: medRxiv preprint Australian Government Department of Health. Coronavirus (COVID-19) current situation and case numbers Novel Coronavirus (2019-nCoV) Situation Report -1 Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness. medRxiv COVID-19 and Italy: what next? COVID-19 in the USA: a question of time Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore Coronavirus Disease-19: Summary of 2,370 Contact Investigations of the First 30 Cases in the Republic of Korea PM Lee Hsien Loong on the COVID-19 situation in Singapore on 3 Australian Government Department of Health. Australian Health Protection Principal Committee (AHPPC) novel coronavirus statement on 1 Assessing the risk of spread of COVID-19 to the Asia Pacific region. medRxiv Novel Coronavirus (2019-nCoV) Situation Report -22 Australian Government Department of Health. 2019-nCoV acute respiratory disease